Summary

Respiratory disorders in Spain represent a significant and mounting public health concern, marked by a complex interplay of factors that are reshaping the healthcare landscape in the country. According to one of the research paper, there were 98,714 deaths due to respiratory diseases in 2021 in Spain, corresponding to 21.9% of all deaths, becoming second in the ranking of causes of death. Respiratory diseases mortality in Spain has not returned to pre-pandemic levels in 2021, still with an increase of 30.3% compared to rates in 2019. Spain's aging population is also contributing to the increased burden, as respiratory diseases tend to be more prevalent among older individuals. Additionally, lifestyle factors, such as smoking and sedentary habits, further compound the issue. The Spanish healthcare system, recognizing the importance of addressing these challenges, has implemented measures to improve air quality, promote smoking cessation, and expand access to healthcare services for early diagnosis and management of respiratory disorders. Nevertheless, the growing burden of respiratory conditions underscores the need for continued efforts in public health awareness, research, and healthcare infrastructure to mitigate the impact of these disorders and enhance the respiratory health of the population.

According to the research report "Spain Respiratory Care Devices Market Overview, 2028," published by Bonafide Research, the market is anticipated to add more than 6 Million from 2023 to 2028. The respiratory care devices market in Spain has witnessed a significant increase in recent years, reflecting a growing recognition of the importance of respiratory health and the country's commitment to providing advanced medical solutions. Spain, like many other nations, is grappling with the challenges posed by an aging population and an increasing prevalence of respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea. The rising incidence of these disorders has generated a sustained demand for a broad spectrum of respiratory care devices, ranging from inhalers and nebulizers to oxygen concentrators and ventilators, designed to enhance the quality of patient care and improve treatment outcomes. Spain's commitment to providing high-quality healthcare services and its adherence to rigorous regulatory standards ensure that respiratory care devices manufactured in the country meet stringent safety and efficacy requirements, instilling confidence in both domestic and international markets. The Spanish healthcare sector has also been characterized by a commitment to innovation, research, and development, resulting in the introduction of state-of-the-art technologies that enhance patient care, offer greater comfort, and contribute to improved patient outcomes.

In Spain, the respiratory equipment market is strategically divided into therapeutic devices, monitoring devices, diagnostic devices, and consumables and accessories. Among these categories, therapeutic devices undeniably take the lead, asserting their dominance with a significant market share. This supremacy can be attributed to the growing prevalence of respiratory conditions in Spain, including asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. These ailments require a wide range of therapeutic solutions, and thus, devices such as inhalers, nebulizers, and continuous positive airway pressure (CPAP) machines have become indispensable in managing and improving the quality of life for individuals afflicted by these respiratory disorders. This high demand for therapeutic devices reflects the commitment of healthcare providers and the medical community in Spain to offer effective solutions for respiratory health. Monitoring devices, diagnostic devices, and consumables and accessories also play significant roles in Spain's respiratory equipment market. Monitoring devices, including pulse oximeters and spirometers, offer essential tools for healthcare professionals to track the vital parameters of respiratory patients, enabling early intervention and precise disease management. Diagnostic devices, encompassing advanced imaging technologies and pulmonary function tests, are pivotal for accurate and timely diagnoses. In the context of the respiratory equipment market in Spain, disease indications represent a pivotal and dynamic aspect of healthcare, with several conditions influencing the demand for respiratory devices. Chief among these is chronic obstructive pulmonary disease (COPD), which emerges as the market leader, holding a prominent position. The prevalence of COPD in Spain, characterized by chronic bronchitis and emphysema, has been steadily increasing due to factors like smoking and aging populations. As a result, the demand for therapeutic and supportive devices such as inhalers, nebulizers, and oxygen therapy solutions has seen significant growth, underpinning COPD's dominance in the market. COPD is a chronic and progressive condition, emphasizing the need for long-term management and advanced respiratory equipment, making it a driving force in the industry.

The respiratory equipment market encompasses a diverse array of disease indications that significantly influence the demand for specialized respiratory devices. Chronic obstructive pulmonary disease (COPD) stands out as a key player in the market, commanding substantial attention and necessitating a range of therapeutic solutions. The multifaceted nature of disease indications within the Spanish respiratory equipment market reflects the pressing need for a variety of devices to address the diverse healthcare challenges posed by these conditions. As Spain continues to emphasize healthcare advancements and tailored patient care, the market remains adaptable and responsive to the diverse needs of individuals with respiratory disorders, thereby emphasizing the ongoing evolution and innovation within the healthcare sector. In Spain, the landscape of end users in the respiratory equipment market is notably led by hospitals, signifying a dominant position within the industry. These healthcare institutions play a pivotal role in shaping the market due to their extensive resources, specialized care, and advanced medical infrastructure. Hospitals serve as the primary centers for providing acute and specialized respiratory care to a broad spectrum of patients suffering from various respiratory conditions such as COPD, asthma, and sleep apnea. Equipped with a wide array of respiratory devices, including ventilators, oxygen delivery systems, and sophisticated monitoring equipment, hospitals stand as critical hubs for delivering comprehensive and immediate care to individuals with severe respiratory ailments.

Considered in this report:
• Geography: Spain
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Spain Respiratory Care Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type:
• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents